Cancer Causes, Screening and Diagnosis
A section of Cancers (ISSN 2072-6694).
Section Information
The future of cancerology, considering environmental pollution and technological advancements in cancer screening and diagnosis, is dependent on our efforts today toward better identifying the causes of cancer, improving screening and, also, the establishment and use of new diagnostic tests.
The section “Cancer Causes, Screening and Diagnosis” should provide essential data for the identification of carcinogens linked to physical, chemical, and biological causes as well as social, mental, and behavioral origins by exploration of the responsible molecules.
The physiological and genetic impacts in relation to the occurrence of cancer will be determined. Modern methods in medical imaging and personalized screening could thus help guide clinical decision-making.
This section will promote the rapid publication of contributions on all aspects of the causes of cancer. We encourage the submission of manuscripts that will assess the “physical, chemical, biological, and social” environmental impacts in oncology, and also all methodologies for cancer screening and diagnosis. Systematic reviews and articles relating to significant progress in this area will be included.
➢ Cancer causesMicroenvironments
- Chemical cancerogenesis
- Physical cancerogenesis
- Irradiation
- Biological cancerogenesis
- Viruses and their pathways
- Bacteria and their pathway
- miRNA axis
- Circular RNA axis
- Social impact
- Habit courants
- Behavioral impact
- Biopsies, cytology
- Cancer-associated antigens
- Circulating DNA and RNA/oligos
- Viral infection
- Bacterial infection
- Endoscopy
- Sonography
- Radiology: tomography (TDM, TEP), scintigraphy, MRI, PET scanning, etc.
- Personalized screening
- Markers:
- Protein and carbohydrate biomarkers in biological liquids (blood, pleura, peritonea, urinary)
- Immunopathological biomarkers
- Circulating nucleotides
- DNA, RNA, histone complex
- miRNAs
- Circular DNA
- Gene analysis and mutagenesis
- Heteroploid cells
- Circulating cancer cells
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Circulating Tumor DNA for MRD Detection (Deadline: 15 June 2023)
- Decoding Cancer Signals Using Liquid Biopsy (Deadline: 20 June 2023)
- Hyperspectral and Multispectral Imaging Applications in Cancer Diagnosis and Detection (Deadline: 30 June 2023)
- Pleiotropic Cancer Susceptibility of Germline BRCA1/2 Mutations (Deadline: 15 August 2023)
- Screening and Early Detection of HPV-Related Cancers (Deadline: 10 September 2023)
- Diagnosis and Innovative Treatment of Localized Lung Cancer (Deadline: 10 September 2023)
- Metastatic Renal Cell Carcinoma – from Diagnosis to Therapy (Deadline: 15 September 2023)
- Head and Neck Cancer Imaging and Image Analysis (Deadline: 30 September 2023)
- Critical Advances in the Diagnosis and Treatment of High-Grade Gliomas (Deadline: 30 September 2023)
- MRI in Prostate Cancer (Deadline: 15 November 2023)
- New Perspectives on Multiple Endocrine Neoplasia (Deadline: 15 November 2023)
- Prevention and Screening in Gynaecological Cancers (Deadline: 20 November 2023)
- Advances in the Diagnosis and Management of Uterine Sarcomas (Deadline: 30 November 2023)
- Magnetic Resonance Imaging in Renal Cell Carcinoma (Deadline: 30 November 2023)
- Diagnosis of Hematologic Malignancies (Deadline: 1 December 2023)
- Gastrointestinal Malignancies in the Era of Precision Oncology: From Bench to Bedside and Back Again (Volume II) (Deadline: 15 December 2023)
- Causes, Consequences, Challenges and Opportunities of Tumor Angiogenesis (Deadline: 15 December 2023)
- Innovations in Soft Tissue Sarcoma Diagnosis and Treatment (Deadline: 15 December 2023)
- The Applications of Radiomics in Precision Diagnosis and Treatment of Solid and Hematological Tumors (Deadline: 15 December 2023)
- Modern Evaluation and Treatment of Malignant Pancreatic, Liver and Biliary Tract Tumours (Deadline: 20 December 2023)
- Gynecologic Cancer: From Diagnosis to Treatment (Deadline: 30 December 2023)
- The Role of Endoscopy in Gastrointestinal Cancers (Deadline: 30 December 2023)
- Interventions Facilitating Patient-Mediated or Provider-Mediated Cancer Predisposition Cascade Genetic Screening (Deadline: 31 December 2023)
- Skin Cancer: Recent Advances in Diagnosis, Treatment, and Prevention (Deadline: 31 December 2023)
- Brain and Spinal Cord Tumors: Symptoms, Diagnosis, and Treatment (Deadline: 31 December 2023)
- Risk Factor Prediction, Diagnosis and Treatment of Breast Cancer (Deadline: 31 January 2024)
- Cancer Genomics: Interpreting the Changing Landscape in Cancer Diagnosis and Treatment (Volume II) (Deadline: 1 February 2024)
- Quantitative Imaging and Digital Pathology in Clinical Cancer Research (Deadline: 29 February 2024)
- Artificial Intelligence in Cancer Screening (Deadline: 31 March 2024)
- Breast Cancer Imaging: Current Trends and Future Direction (Deadline: 31 March 2024)
- Novel Developments in Invasive Lobular Breast Cancer: Diagnosis, Prognosis and Therapy (Deadline: 30 April 2024)
- MRI-Assisted Radiosurgery (MARS) (Deadline: 31 May 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
